Clinical
Trials
Finder
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Search
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Conditions
Non-Small Cell Lung Cancer With EGFR Mutation
Nanjing, Jiangsu
Non-Small Cell Lung Cancer With EGFR Mutation Clinical Trials in Nanjing, Jiangsu
1 recruiting
Nanjing, Jiangsu, China
Showing
1–1
of
1
trials
Recruiting
Phase 1
Phase 2
A Phase Ib/II Clinical Study of GH21 Capsules Combined With Osimertinib Mesylate Tablets in Patients With NSCLC
Non-Small Cell Lung Cancer With EGFR Mutation
Suzhou Genhouse Bio Co., Ltd.
94 enrolled
6 locations
NCT06306456
Feedback